Delivery Order SPE2DB24D2101-SPE2DB25FKPSU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,080.48 to AmerisourceBergen Drug Corp on June 3, 2025, for WIXELA 500-50 INHUB 60S, a pharmaceutical product for inhalation treatment. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order draws from AmerisourceBergen's...
- This delivery order, valued at $1,373.64, was awarded to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Wixela 500-50 Inhub 60s pharmaceutical product. The contract, issued by the Defense Logistics Agency (DLA), carries a firm fixed price structure with no set-aside designation and is scheduled for completion by August 1, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,231.35 for WIXELA 250-50 INHUB 60S, a pharmaceutical product, with a completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child task order under AmerisourceBergen Drug Corp's larger contract vehicle with the...
- The Defense Logistics Agency (DLA) awarded a $2,488.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S, a pharmaceutical product. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 18, 2025, and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. This delivery order represents a single transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $2,209.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S pharmaceutical products, with an ultimate completion date of June 23, 2025. This non-set-aside competitive award was issued on June 20, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This delivery order, issued by the Defense Logistics Agency (DLA), awards AmerisourceBergen Drug Corp $1,378.26 for the supply of Wixela 500-50 Inhub 60S, a pharmaceutical product, with completion scheduled for September 8, 2025. The contract employs firm fixed pricing and was competitively awarded without a set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,512.97 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S, a pharmaceutical product used in respiratory treatment. This firm fixed price delivery order, issued on April 29, 2025, with an ultimate completion date of April 30, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,948.02 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,496.16 to AmerisourceBergen Drug Corp on September 3, 2025, for WIXELA 250-50 inhaler units (60-count). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a...
- The Defense Logistics Agency awarded a $1,564.83 delivery order to AmerisourceBergen Drug Corp for WIXELA 500-50 inhaler products on June 2, 2025, with an ultimate completion date of June 3, 2025. This contract was issued under firm fixed pricing with no set-aside designation, indicating competitive award conditions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a child delivery order, this award is...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPSUDelivery Order
This delivery order, valued at $1,006.56, was awarded on September 18, 2025, to AmerisourceBergen Drug Corp for the supply of WIXELA 500-50 INHUB 60S, a pharmaceutical product. The contract is a firm fixed price delivery order with no set-aside designation, issued by the Defense Logistics Agency (DLA), a defense agency component of the Department of Defense. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery order represents a competitively awarded transaction under AmerisourceBergen Drug Corp's existing federal contract portfolio. This award is a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard through a flexible procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/18/25 |